- Report
- August 2025
- 197 Pages
Global
From €3135EUR$3,545USD£2,716GBP
€3483EUR$3,939USD£3,018GBP
- Report
- August 2025
- 180 Pages
Global
From €3135EUR$3,545USD£2,716GBP
€3483EUR$3,939USD£3,018GBP
- Report
- August 2025
- 191 Pages
Global
From €3135EUR$3,545USD£2,716GBP
€3483EUR$3,939USD£3,018GBP
- Report
- May 2025
- 137 Pages
Global
From €2652EUR$2,999USD£2,298GBP
- Report
- July 2025
- 120 Pages
Global
From €5262EUR$5,950USD£4,559GBP
- Report
- May 2025
- 130 Pages
Global
From €5262EUR$5,950USD£4,559GBP
- Report
- March 2025
- 210 Pages
Global
From €5262EUR$5,950USD£4,559GBP
- Report
- February 2025
- 120 Pages
Global
From €5262EUR$5,950USD£4,559GBP
- Report
- September 2024
- 150 Pages
Global
From €5262EUR$5,950USD£4,559GBP
- Report
- September 2024
- 120 Pages
Global
From €5262EUR$5,950USD£4,559GBP
- Report
- January 2025
- 175 Pages
Global
From €3971EUR$4,490USD£3,440GBP
- Report
- January 2025
- 175 Pages
Global
From €3971EUR$4,490USD£3,440GBP
- Report
- January 2025
- 175 Pages
Global
From €3971EUR$4,490USD£3,440GBP
- Report
- January 2025
- 175 Pages
Global
From €3971EUR$4,490USD£3,440GBP
- Report
- August 2025
- 218 Pages
Global
From €5173EUR$5,850USD£4,482GBP
- Report
- August 2025
- 150 Pages
Global
From €3405EUR$3,850USD£2,950GBP
- Report
- August 2025
- 150 Pages
Global
From €3405EUR$3,850USD£2,950GBP
- Report
- November 2024
- 150 Pages
Global
From €3405EUR$3,850USD£2,950GBP
€4289EUR$4,850USD£3,716GBP
- Report
- September 2024
- 150 Pages
Global
From €3405EUR$3,850USD£2,950GBP
€4289EUR$4,850USD£3,716GBP
- Report
- May 2025
- 175 Pages
Global
From €3971EUR$4,490USD£3,440GBP

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy.
The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes.
The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more